Benefits, Risks of Dolutegravir Center Stage at AIDS 2018 Benefits, Risks of Dolutegravir Center Stage at AIDS 2018

Potentially game-changing data on HIV treatment will be presented at the International AIDS Conference, but policies that make treatment and prevention difficult will also be discussed.Medscape Medical News

Source: Medscape Hiv-Aids Headlines - July 17, 2018 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news